Certara stock.

PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to ...Dec 1, 2023 · Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio. Nov 23, 2023 · Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%. Certara Inc Follow Share $14.64 After Hours: $14.64 (0.00%) 0.00 Closed: Dec 1, 4:03:07 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Exscientia PLC $6.17 EXAI1.15% Amazon.com Inc...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Certara fair value estimate is US$18.83 Certara is estimated... Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing. Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Certara, Inc.'s business for stockholders, potential investors, and financial analysts.

OPGN | Complete OpGen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock ... Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.... stock price by the number of shares outstanding. Certara market cap as of December 01, 2023 is $2.34B. Compare CERT With Other Stocks. Sector, Industry, Market ...

From Nasdaq : Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $500 million. The company uses its biosimulation software and technology to ...

Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis.

Mar 22, 2021 · Certara, Inc. (“Certara”), a global leader in biosimulation, today announced a proposed underwritten public offering of 17 million shares of its common stock being offered by selling stockholders. Additionally, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to 2,550,000 additional shares of common ... Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago. These figures are ...Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...11 Des 2020 ... Certara CEO on strong IPO debut. CNBC's “Squawk Alley” team ... Global Business and Financial News, Stock Quotes, and Market Data and Analysis.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. The estimated Net Worth of Richard M. Traynor is at least $9.96 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,353,865 and over the last 2 years he sold CERT stock worth over $5,603,360.Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...21 Seconds 22 -40% on all our subscriptions* Exceptional extension! Enjoy this offer * See conditions on site Financials (USD) More Fundamentals * Assessed data …Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...

4 Apr 2023 ... Certara (CERT), a developer of biosimulation software for drug discovery, dropped Tuesday after Barclays downgraded on valuation concerns.

Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free RegistrationNov 27, 2022 · ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ... 9/30/2023, ALYESKA INVESTMENT GROUP LP Bought 1.6 Million shares of Certara Inc. 9/30/2023, RATHBONES INVESTMENT MANAGEMENT ... Bought 757.0 Thousand shares ...Certara is listed on the Nasdaq stock exchange under the ticker symbol “CERT.” When did Certara go public, and what was the offering price? Certara’s initial public offering was on December 11, 2020 at $23 per share.Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. The institutional investor owned 3,910,996 shares of the company's stock after buying an additional 346,460 shares during the quarter. JPMorgan Chase & Co. owned about 2.45% of Certara worth $84,008,000 at the end of the most recent reporting period. A number of other hedge funds have also added to or reduced their stakes in the stock.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.The estimated Net Worth of Richard M. Traynor is at least $8.76 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,938,988 and over the last 3 years he sold CERT stock worth over $5,825,760.Sep 13, 2023 · With a price of $14.6 and a GuruFocus Value of $25.18, the stock has a price-to-GF-Value ratio of 0.58. Story continues Despite the insider's recent sell, the undervaluation of Certara Inc's stock ...

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.

Real time Certara (CERT) stock price quote, stock graph, news & analysis.

Share WA. Call · Chat WA · Facebook Twitter Youtube. Tanyakan tentang properti ini. Halo, saya tertarik dengan [RUMAH Cluster Certara Park Citra Raya – Cikupa].Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 5 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick exercised 8,646 units of CERT stock worth $181,307 on 31 March 2023.8,646 units of CERT stock worth $181,307 on 31 March 2023.Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ...How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday …What is the support and resistance for Certara (CERT) stock price? CERT support price is $14.50 and resistance is $15.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT stock …As of now, Certara’s stock opened at $18.19 on Friday, with a market cap of $2.91 billion. The company has a price-to-earnings ratio of 202.11 and a price-to-earnings-growth ratio of 0.96, indicating the market’s confidence in its future growth potential. Certara’s beta stands at 1.58, reflecting its sensitivity to market volatility.Matthew Walsh CERT stock SEC Form 4 insiders trading. Matthew has made over 12 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently Matthew exercised 9,067 units of CERT stock worth $135,733 on 17 May 2023.. The largest trade Matthew's ever made was exercising 102,043 units of …Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ...Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, …Mar 10, 2023 · Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.

Which Certara insiders have been buying company stock? The following insiders have purchased CERT shares in the last 24 months: Eran Broshy ($3,107.30), Michael Andrew Schemick ($416,000.00), and Stephen M Mclean ($326,400.00).Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipThe high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Instagram:https://instagram. nova nordisk stockkevin o leary investment appsafe stock to buytd ameritrade forex How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.11 Des 2020 ... Certara CEO on strong IPO debut. CNBC's “Squawk Alley” team ... Global Business and Financial News, Stock Quotes, and Market Data and Analysis. xbi stocksday trader websites The latest price target for . Certara (NASDAQ: CERT) was reported by Stephens & Co. on April 12, 2023.The analyst firm set a price target for $28.00 expecting CERT to rise to within 12 months (a ... nyse pbt Dec 1, 2023 · 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price. Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile.